2025’s Therapy Area Growth Drivers And Brakes: Part Three
Executive Summary
The final instalment of In Vivo’s three-part series delves into the therapeutic categories that will propel forecast pharmaceutical sales growth for 2025, focusing on mood disorders, immunodeficiency, viral infections, and blood cell disorders.